Swap vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 31)

Swap

EmergingE-commerce

General

London D2C e-commerce OS (founded 2022); $40M ICONIQ Growth Series B (March 2025) after 7x revenue growth with Importer of Record model serving 500+ fashion brands ($20M-$100M) competing with Global-e for cross-border operations.

AI VisibilityBeta
Overall Score
D31
Category Rank
#671 of 1167
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
33
Perplexity
33
Gemini
39

About

Swap is a London, United Kingdom-based e-commerce operating system for direct-to-consumer brands — backed with approximately $49 million in total funding including a $40 million Series B in March 2025 led by ICONIQ Growth with Cherry Ventures, QED Investors, and 9900 Capital — providing a unified platform for cross-border logistics, inventory management, and international operations that reduces operational costs by up to 30% and improves revenue by 8% for 500+ fashion, eyewear, and lifestyle brands. Founded in 2022 by CEO Sam Atkinson and CPO Zach Bailet (whose direct experience running a cross-border e-commerce business sourcing from Africa informed the platform's design), Swap achieved 7x revenue growth between March 2024 and March 2025. Brands including 3.1 Phillip Lim, Sandy Liang, Ed Hardy, Pangaia, The Frankie Shop, and Odd Muse (typically $20M-$100M annual sales) rely on Swap for Importer of Record services, delivered duty paid (DDP) shipping, automated tax remittance, and express customs clearance across 190+ countries. Swap Inventory (AI-powered demand forecasting and smart restocking) launched in 2025 alongside expansion to Australia and Canada.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

31
Overall Score
90
#671
Category Rank
#9
83
AI Consensus
60
stable
Trend
stable
33
ChatGPT
99
33
Perplexity
99
39
Gemini
83
35
Claude
96
38
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.